BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 801216)

  • 1. Enhancement of canine renal allografts. II. Studies with Fab fragments.
    Martin DC; Blackwelder R; Rasband R; Morton ME
    Trans Am Assoc Genitourin Surg; 1976; 68():99-101. PubMed ID: 801216
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal transplantation in rabbits. VII. IgG deposits in allografts from recipients with lymphocytotoxic antibodies induced by multiple skin-grafts.
    Lund B; Hansen ES
    Acta Pathol Microbiol Scand A; 1972; 80(3):391-402. PubMed ID: 4558136
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of anti-Fab and anti-IgG antibodies with high kidney transplant survival.
    Chia D; Horimi T; Terasaki PI; Hermes M
    Transplant Proc; 1982 Jun; 14(2):322-4. PubMed ID: 7051474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful enhancement of canine renal allografts.
    Martin DC
    Invest Urol; 1973 Sep; 11(2):165-9. PubMed ID: 4580546
    [No Abstract]   [Full Text] [Related]  

  • 5. The protective effect of F(ab') 2 and succinylated IgG in the early treatment of hyperacute rejection in the primate.
    Habal MB; Carpenter CB; Kobayashi K; Bush GJ; Misra M; Birtch AG
    Transplant Proc; 1973 Mar; 5(1):601-6. PubMed ID: 4633093
    [No Abstract]   [Full Text] [Related]  

  • 6. Passive enhancement of canine renal allografts with polyspecific F(ab')2 fragments.
    Wren SF; Martins AC; Von Haefen U; Busch GJ; Katske GE; Koppenheffer TL; Shaipanich T; Wilson RE
    Surgery; 1974 Jul; 76(1):112-20. PubMed ID: 4135410
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of pretreatment with multiple blood transfusions and with skin grafts on the survival of renal allografts in mongrel dogs.
    Abouna GM; Barabas AZ; Pazderka V; Boyd N; Vetters JM; Kinniburgh DW; Lao VS; Schlaut J; Kovithavongs T; Dossetor JB
    Transplant Proc; 1977 Mar; 9(1):265-8. PubMed ID: 325764
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of organ specificity in renal allograft enhancement with F(ab') 2 fragments.
    Shaipanich T; Wren S; von Haefen U; Koppenheffer T; Busch G; Wilson RE
    Transplant Proc; 1973 Mar; 5(1):581-3. PubMed ID: 4572116
    [No Abstract]   [Full Text] [Related]  

  • 9. Survival of canine renal allografts after treatment with polyspecific F(ab')2 fragments.
    Abouna GM; Garver FA; Kogure H; DeLong TG; Andres GA
    Surg Forum; 1973; 24():318-20. PubMed ID: 4618655
    [No Abstract]   [Full Text] [Related]  

  • 10. B-lymphocyte and kidney cell cross-reactive antibodies eluted from rejected human renal allografts.
    Mohanakumar T; Siegel W; Mendez G; Kaplan AM; Lee HM
    Transplant Proc; 1979 Dec; 11(4):1896-8. PubMed ID: 394434
    [No Abstract]   [Full Text] [Related]  

  • 11. Active or passive enhancement and allograft survival.
    Wilson RE
    Transplant Proc; 1972 Dec; 4(4):513-5. PubMed ID: 4405144
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal transplantation in rabbits. IX. An immunological study of the allograft reaction in rabbits pre-sensitized by donor kidney homogenate.
    Hansen ES; Lund B; Ahrons S
    Acta Pathol Microbiol Scand A; 1972; 80(6):827-34. PubMed ID: 4144026
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of antigen pretreatment on canine renal allograft survival.
    Holl-Allen RT
    Ann R Coll Surg Engl; 1971 Jul; 49(1):1-17. PubMed ID: 4934110
    [No Abstract]   [Full Text] [Related]  

  • 14. Cellular and humoral factors governing canine mixed lymphocyte cultures after renal transplantation. I. Antibody.
    Miller J; Hattler B; Davis M; Johnson MC
    Transplantation; 1971 Jul; 12(1):65-76. PubMed ID: 4932699
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet survival test. An accurate prediction of hyperacute rejection of renal allografts in rabbits.
    Andersen OS; Tissot RG; Cohen C; Jonasson O
    Transplantation; 1973 Jan; 15(1):105-10. PubMed ID: 4575916
    [No Abstract]   [Full Text] [Related]  

  • 16. Passive enhancement of cadaver renal allografts: a prospective randomized trial of F(ab')2 therapy.
    Wilson RE; Garovoy MR; Strom TB; Lowry RP; Busch GJ; Vineyard GC; Tilney NL
    Transplant Proc; 1981 Mar; 13(1 Pt 1):531-2. PubMed ID: 7022888
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antibody formation in patients and the time periods of kidney allograft functioning].
    Tsygankova ST; Belorusov OS; Boĭko OV
    Sov Med; 1984; (1):39-43. PubMed ID: 6367088
    [No Abstract]   [Full Text] [Related]  

  • 18. Isolation and characterization of antibodies and other immunologically reactive substances from rejecting renal allografts.
    Hampers CL; Kolker P; Hager EB
    J Immunol; 1967 Sep; 99(3):514-25. PubMed ID: 4860923
    [No Abstract]   [Full Text] [Related]  

  • 19. The significance of antivascular endothelium antibody in renal transplantation.
    Cerilli J; Jesseph JE; Miller AC
    Surg Gynecol Obstet; 1972 Aug; 135(2):246-52. PubMed ID: 4559046
    [No Abstract]   [Full Text] [Related]  

  • 20. The absence of early rejection crises in human renal allografts as predicted by capillary agglutinating antibodies.
    Stiller CR; Olson R; Haystead J; Dossetor JB
    Transplantation; 1972 Oct; 14(4):521-3. PubMed ID: 4566168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.